Feedback

Browsing by D

Use an asterisk (*) for partial word searches (e.g. pemph*)

80 results found.

1.
2.
3.
Ordering Recommendation:   Aid in diagnosing and following DIC.
4.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
5.
Ordering Recommendation:   Use in conjunction with histologic and clinical information for the diagnosis of round cell/myxoid liposarcoma.
6.
Ordering Recommendation:   Panel not recommended for screening celiac disease. Preferred screening test is Celiac Disease Reflexive Cascade (2008114) or Tissue Transglutaminase (tTG) Antibody, IgA (0097709) testing for individuals with normal levels of serum IgA.
7.
Ordering Recommendation:   Acceptable single screening test for celiac disease. IgA testing recommended to identify IgA deficiency. Use IgA test in individuals who are IgA competent. May be useful in diagnosing children <2 years who test negative for tTG and EMA antibodies. May aid in monitoring adherence to gluten-free diet. Celiac Disease Reflexive Cascade (2008114) or Tissue Transglutaminase (tTG) Antibody, IgA (0097709) is the preferred test for screening patients with suspected celiac disease.
8.
Ordering Recommendation:   Acceptable single screening test for celiac disease. IgA testing recommended to identify IgA deficiency. Use IgG test in individuals who are IgA deficient. May be useful in diagnosing children <2 years who test negative for tTG and EMA antibodies. May aid in monitoring adherence to gluten-free diet. Celiac Disease Reflexive Cascade (2008114) or Tissue Transglutaminase (tTG) Antibody, IgG (0056009) is the preferred test for screening patients with suspected celiac disease.
9.
Ordering Recommendation:   Indicator of adrenal androgen production. Aids in the investigation of virilizing endocrinopathies in conjunction with other sex steroids. Not recommended for initial evaluation of polycystic ovarian syndrome.
10.
Ordering Recommendation:   Adjunct test for the investigation of hyperandrogenic and adrenal disorders. Not recommended for initial evaluation of polycystic ovarian syndrome.
11.
12.
13.
14.
Ordering Recommendation:   Diagnose Dengue fever infection during the intial stage of infection (1-5 days) after onset of symptoms. Test detects and differentiates Dengue subtypes 1-4. Do not order prior to serology testing.
15.
16.
Ordering Recommendation:   Surveillance and monitoring of hepatocellular carcinoma.
17.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence. Test only measures desipramine concentration. If imipramine will be administered, order Imipramine and Desipramine (0090157).
18.
Ordering Recommendation:   Refer to ARUP Immunohistochemistry Stain Offerings brochure at www.aruplab.com/ap/resources.
19.
Ordering Recommendation:   Monitor disease in patient previously diagnosed with pemphigus and increased IgG desmoglein 1 and/or 3 antibodies; antibody levels correlate with disease activity. Consider ordering with IgG epithelial cell surface antibody (0090266).
If used to screen for pemphigus, this test has decreased sensitivity and specificity when compared to the pemphigus antibody panel (0090650).
For initial diagnosis and monitoring disease, the antibody panel testing for pemphigus (0090650) is preferred; panel components include IgG antibody testing for epithelial cell surface and IgG desmoglein 1 and 3.
For diagnosing rare types of pemphigus, refer to IgA pemphigus antibody (0092106) and paraneoplastic pemphigus (0092107).
20.
Ordering Recommendation:   Compliance assessment of dexamethasone suppression testing.
21.
Ordering Recommendation:   Refer to Additional Technical Information document.
22.
Ordering Recommendation:   Refer to Additional Technical Information document.
23.
Ordering Recommendation:   Refer to Additional Technical Information document.
24.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
25.
26.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence. Does not measure digoxin (Lanoxin, Digitek); for digoxin testing, order digoxin test (0090080).
27.
28.
Ordering Recommendation:   Predict risk of dose-related toxicity to 5-FU therapy.
29.
Ordering Recommendation:   Refer to Additional Technical Information document.
30.
Ordering Recommendation:   Preferred test is a reflex panel [Lupus Anticoagulant Reflexive Panel (0030181)].
31.
32.
33.
Ordering Recommendation:   Determine IgG antibodies in response to protein antigen vaccination (pre- and/or post-vaccination).
34.
35.
Ordering Recommendation:   Determine IgG antibody titers in response to vaccination with protein and protein conjugated antigens. Determine IgG antibody titers to tetanus and diphtheria toxoids and H. influenzae PRP simultaneously.
36.
37.
Ordering Recommendation:   Determine presence of immunoglobins and complement degradation products.
38.
39.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
40.
41.
42.
43.
Ordering Recommendation:   May aid in evaluating the prognosis of malignancy in a variety of tumor specimen types. For cell cycle and DNA ploidy studies in products of conception specimens, refer to Products of Conception, Ploidy by Flow Cytometry (2006178).
44.
45.
46.
Ordering Recommendation:   Screening test in tumor that is morphologically and clinically suspicious for GIST when CD117 is negative.
47.
48.
Ordering Recommendation:   Secondary screening for systemic lupus erythematosus (SLE) based on ANA results.
49.
Ordering Recommendation:   Secondary screening for systemic lupus erythematosus (SLE) based on ANA results.
50.
Ordering Recommendation:   Optimize drug therapy and monitor patient adherence.
51.
Ordering Recommendation:   Preferred multidrug panel test for monitoring patient adherence. This is a high resolution test which eliminates need for secondary (confirmation) testing.
52.
Ordering Recommendation:   Detect and document maternal drug use during approximately the last trimester of a full term birth.
53.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure.
54.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure.
55.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure.
56.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out drug exposure.
57.
Ordering Recommendation:   Detect overdose exposure.
58.
Ordering Recommendation:   Useful in situations where identity or class of the drug or drugs of interest is not known. Not recommended for assessment in routine compliance and/or abuse contexts.
59.
Ordering Recommendation:   Monitor patient compliance.
60.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 7, Urine - Screen with Reflex to Confirmation/Quantitation (0092184) is recommended.
61.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 7A, Urine - Screen with Reflex to Confirmation/Quantitation (0092185) is recommended.
62.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 9, Urine - Screen with Reflex to Confirmation/Quantitation (0092186) is recommended.
63.
Ordering Recommendation:   Useful for general screening in contexts of compliance and/or abuse. For follow-up testing of a presumptive result, confirmatory testing by mass spectrometry is recommended. For automatic reflex testing on all presumptive positives, Drug Panel 9A, Urine - Screen with Reflex to Confirmation/Quantitation (0092187) is recommended.
64.
65.
66.
67.
68.
69.
Ordering Recommendation:   Detect and document maternal drug use during approximately the last trimester of a full term birth.
70.
71.
72.
Ordering Recommendation:   Urine screening and confirmation test to identify acute alcohol ingestion.
73.
Ordering Recommendation:   Appropriate first-tier genetic test for Duchenne and Becker muscular dystrophy.
74.
Ordering Recommendation:   Most comprehensive genetic test for Duchenne and Becker muscular dystrophy. If no large DMD deletions/duplications are detected, testing will reflex to DMD sequencing.
75.
Ordering Recommendation:   Prenatal test for known DMD gene deletions/duplications previously identified in a family member. Please contact an ARUP genetic counselor at (800) 242-2787 extension 2141 prior to ordering.
76.
Ordering Recommendation:   Order ONLY if previous DMD gene deletion/duplication testing did not identify a causative mutation. Not recommended as initial test for Duchenne or Becker muscular dystrophy. Recommended first-tier tests are DMD Deletion/Duplication with Reflex to Sequencing (2011241) or DMD Deletion/Duplication (2011235).
77.
78.
Ordering Recommendation:   Diagnostic testing for familial dysautonomia. Carrier screening for familial dysautonomia.
79.
Ordering Recommendation:   Refer to Additional Technical Information document.
80.
Ordering Recommendation:   Refer to Additional Technical Information document.